Cemindia Projects allots equity shares worth ₹1,400.00 Crore in QIP
Cemindia Project · Construction
What the filing says
- Allotted 1,26,35,379 Equity Shares at ₹1,108.00 each, including ₹1,107.00 premium, aggregating ₹1,400.00 Crore
- Issue opened October 14, 2026 and closed October 19, 2026; Management Committee approved allotment on October 19, 2026
- Allottees at 5% or more on PAN clubbed basis include Motilal Oswal 46.43%, Mirae Asset 8.57%, Tata 5.71%, Bank of India 5.71%, Aditya Birla Sun Life 5.00%, Invesco 5.00%
Why it's rated notable: amount is ₹500 crore or more
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Allotment
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Cemindia Project
- Fundraise / allotmentNotableCemindia Projects closes qualified institutions placement of 1,26,35,379 equity shares
- Fundraise / allotmentNotableCemindia Projects Limited opens qualified institutions placement of equity shares
Other fundraise / allotment filings this fortnight
- Affle 3i allots 12,77,155 equity shares to promoter on warrant conversion
- Persistent Systems approves QIP Issue with floor price of ₹5,550 per share
- OnEMI Technology Solutions gets NSE and BSE in-principle approval for preferential issue
- Regency Fincorp Limited proposes equity share issue, ESOP scheme, and capital increase
- Piramal Finance Q2 standalone profit Rs. 529.21 crores vs Rs. 277.67 crores a year ago
- OSEL Devices appoints Kapil Kohli as Strategic Consultant and approves warrant issue
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.